I called a while back and the trial coodinator said that the trial is still open to enrollment, which means that it is a long way from being completed. I get the feeling that this particular cancer vaccine is not looking promising to the women suffering from ovarian cancer.
Otherwise I think they would have reached their limit by now. Then again, it's possible they're enrolling all comers.
Market Data 
Markets 
AI
